Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 18, 2000

View Archived Issues

Crucell Plans Dual IPO Following Merger Of IntroGene, U-BiSys

Crystal Structure Of DNA Repair Protein May Hold Cancer Clues

UK First Country To Allow Use Of Genetic Testing By Insurers

Genetix Aims To Raise #27M To Boost Sales Force, R&D

Diatos Raises $13M To Fund Cancer, Infection Programs

Bosentan Gains Orphan Status In Pulmonary Hypertension

Cooperative EU-U.S. Biotech Effort Lauded At 10-Year Mark

Transghne, Mirus Collaborate On Gene Transfer Technology

GenOdyssee Attains Genotyping Objective, Plans To Lower Price

Alizyme Sees Positive Results In Phase IIa Study Of Drug For IBS

New Chairman, Secretary General Settle Into EuropaBio Positions

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.